Yüklüyor......
Molecularly targeted drugs for metastatic colorectal cancer
The survival rate of patients with metastatic colorectal cancer (mCRC) has significantly improved with applications of molecularly targeted drugs, such as bevacizumab, and led to a substantial improvement in the overall survival rate. These drugs are capable of specifically targeting the inherent ab...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3817019/ https://ncbi.nlm.nih.gov/pubmed/24204124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S52485 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|